↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$639KSold on the market
1Companies
Oct 2, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:54 | Oct 1, 2026 | XERSXeris Biopharma Holdings, Inc. | See Remarks | S · Sell10b5-1 | $9.41 | −15,000 | 1,599,208 | -1% | −$141K | ||
| Sep 29, 202616:59 | Sep 28, 2026 | XERSXeris Biopharma Holdings, Inc. | See Remarks | S · Sell10b5-1 | $10.00 | −25,000 | 1,614,208 | -2% | −$250K | ||
| Sep 1, 202618:21 | Sep 1, 2026 | XERSXeris Biopharma Holdings, Inc. | See Remarks | S · Sell10b5-1 | $8.49 | −15,000 | 1,639,208 | -1% | −$127K | ||
| Aug 21, 202616:15 | Aug 1, 2026 | XERSXeris Biopharma Holdings, Inc. | See Remarks | F · TaxLate 20d | $8.08 | −21,918 | 1,654,208 | -1% | $177K | ||
| Aug 4, 202617:30 | Aug 3, 2026 | XERSXeris Biopharma Holdings, Inc. | See Remarks | S · Sell10b5-1 | $8.02 | −15,000 | 1,676,126 | -1% | −$120K |